Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Nails Down $2.5B in Financing for ABI Deal

NEW YORK (GenomeWeb News) – Invitrogen said today that it has secured the financing lines it will need to complete its acquisition of Applied Biosystems, a deal valued at around $6.7 billion in cash and stock.
 
Funding for the two loans, which will total around $2.65 billion, came from two groups of lenders. One loan that includes $1.4 billion and a revolving credit facility for $250 million was committed by a group of 30 bank lenders. A second loan of $1 billion will come from 250 committed lenders.
 
“The syndication contains a well-diversified base of domestic and international investors, who see the value in the significant cash flow and future potential of the combined company,” Invitrogen CFO David Hoffmeister said in a statement.
 
The company expects the merger to close in November, once the nod comes from shareholders and the European Commission. The deal has already cleared US antitrust hurdles.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.